• Explore /
  • Poster
  • / Cell-free DNA (cfDNA) analysis and evaluation of BRAF amplifications and mutations in metastatic castration-resistant prostate cancer.

Cell-free DNA (cfDNA) analysis and evaluation of BRAF amplifications and mutations in metastatic castration-resistant prostate cancer.

Abstract Poster

Authors

null

Peter Steinwald

Tulane University School of Medicine, New Orleans, LA

Peter Steinwald , Elisa Ledet , Bryce Raymon Christensen , Marcus Marie Moses , Lynne Chapman , Ashkan Shahbandi , Patrick Cotogno , Joshua Schiff , Jodi Lyn Layton , Brian E. Lewis , A. Oliver Sartor

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer,Prostate Cancer

Sub Track

Prostate Cancer - Advanced Disease

Citation

J Clin Oncol 36, 2018 (suppl 6S; abstr 255)

DOI

10.1200/JCO.2018.36.6_suppl.255

Abstract #

255

Poster Bd #

M9

Abstract Disclosures

Similar Posters

First Author: Aishwarya Subramanian

Poster

2023 ASCO Genitourinary Cancers Symposium

Androgen receptor (AR) mutations in men with metastatic castration-resistant prostate cancer (mCRPC): Incidence and natural history.

Androgen receptor (AR) mutations in men with metastatic castration-resistant prostate cancer (mCRPC): Incidence and natural history.

First Author: Alice Bernard-Tessier

First Author: Kim N. Chi

First Author: Santosh Gupta